• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    UK Depression Screening Mental Health Market

    ID: MRFR/HC/54515-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    UK Depression Screening Mental Health Market Research Report: By Indication (Major Depressive Disorder, Anxiety Distress, Bipolar Disorder, Psychotic Disorders, Others), By Diagnosis (Psychological Tests, Blood Tests, Pharmacogenomic Testing, Others) andBy End User (Hospitals and Clinics, Home-based, Research and Academic Institutes)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    UK Depression Screening Mental Health Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    UK Depression Screening Mental Health Market Summary

    The United Kingdom UK Depression Screening Mental Health market is projected to grow significantly over the next decade.

    Key Market Trends & Highlights

    UK Depression Screening Mental Health Key Trends and Highlights

    • The market valuation is expected to increase from 37.2 USD Million in 2024 to 72.5 USD Million by 2035.
    • A compound annual growth rate (CAGR) of 6.24 percent is anticipated from 2025 to 2035.
    • The growth trajectory indicates a rising awareness and need for effective depression screening solutions in the UK.
    • Growing adoption of digital health technologies due to increased mental health awareness is a major market driver.

    Market Size & Forecast

    2024 Market Size 37.2 (USD Million)
    2035 Market Size 72.5 (USD Million)
    CAGR (2025-2035) 6.24%

    Major Players

    NHS, Samaritans, Mind, Aetna, Psychology Aotearoa, Talkspace, BetterHelp, Cigna, Priory Group, Liva Healthcare, The Royal College of Psychiatrists, Bupa, Peer Support Network, Headspace

    UK Depression Screening Mental Health Market Trends

    The UK Depression Screening Mental Health Market is witnessing several notable trends that reflect the growing awareness and need for effective mental health solutions. One key market driver is the increased recognition of mental health issues among the population. The UK government has placed significant emphasis on mental health, promoting initiatives to destigmatize depression and increase access to screening and treatment. As a result, there is a rising demand for standardized screening tools and methods that can effectively identify depression in various demographics, particularly among young adults and vulnerable populations. 

    Opportunities to be explored include the integration of digital tools and telehealth services in depression screening processes.With the rapid adoption of technology during the pandemic, healthcare providers in the UK are increasingly leveraging online platforms to facilitate mental health assessments. This trend not only improves accessibility for patients but also streamlines the screening process. Additionally, there is potential for developing tailored screening programs for specific groups, such as students, the elderly, or individuals in high-stress jobs. Trends in recent times have also shown a move towards adopting holistic approaches in mental health treatment. 

    This includes not only psychological interventions but also incorporating lifestyle changes and community support systems to address the root causes of depression.There is growing interest in collaborative care models involving multidisciplinary teams that can enhance the effectiveness of depression screening and subsequent treatment. Moreover, the influence of social media in raising awareness about mental health is prompting more individuals to seek help, further driving growth in the screening market. In light of these developments, stakeholders in the UK mental health sector are urged to adapt and innovate to meet the evolving needs of the population.

    UK Depression Screening Mental Health Market Drivers

    Market Segment Insights

    UK Depression Screening Mental Health Market Segment Insights

    UK Depression Screening Mental Health Market Segment Insights

    Depression Screening Mental Health Market Indication Insights

    Depression Screening Mental Health Market Indication Insights

    The UK Depression Screening Mental Health Market has shown noteworthy developments within its Indication segment, reflecting an increased focus on mental health awareness and support across the region. With a growing population in need of mental health care, the implications are significant. Major Depressive Disorder remains a critical concern, as it affects a substantial portion of the UK populace, driving the need for effective screening tools and early intervention methods. The prominence of Anxiety Distress within the market highlights the overwhelming prevalence of anxiety disorders, which often co-occur with depression, creating a dual challenge in screening and treatment.

    Additionally, Bipolar Disorder adds a unique complexity to the mental health landscape, as timely identification is essential for effective management and stabilization. Psychotic Disorders also demand attention due to their severe impact on individuals' daily lives, making accurate screening crucial for timely interventions. Beyond these categories, the 'Others' segment encompasses various depressive and anxiety-related conditions, indicating the diverse range of mental health issues that the market addresses. In the UK, mental health services are evolving, supported by government initiatives to enhance both accessibility and quality of care, thereby fostering an environment conducive to innovative screening solutions.

    Mental health awareness campaigns and an emphasis on reducing stigma around seeking help are further propelling the demand for efficient screening protocols in these segments. The increased integration of technology in mental health care, including digital screening tools and telehealth services, is also expected to transform how these indications are addressed. As the UK grapples with ongoing mental health challenges, the Indication segment of the market is positioned for significant growth, reflecting both the urgent need for comprehensive screening systems and the continuous evolution in understanding mental health disorders.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Depression Screening Mental Health Market Diagnosis Insights

    Depression Screening Mental Health Market Diagnosis Insights

    The Diagnosis segment of the UK Depression Screening Mental Health Market is a critical component in identifying and managing depression among the population. Psychological Tests dominate this segment as they offer effective and efficient means of diagnosing depressive disorders through standardized assessments and questionnaires. Blood Tests are gaining traction as they provide biological insights that could enhance diagnostic accuracy and potentially address underlying physical health issues linked to mental health. Pharmacogenomic Testing plays a pivotal role in personalizing treatment plans, ensuring that patients receive the most suitable medications based on their genetic profiles, thereby improving overall health outcomes.

    Additionally, various other methods are utilized to support diagnosis and further understand the complexities of depression, including comprehensive interviews and observational assessments. The integration of these diverse diagnostic tools reflects a growing trend in the UK to adopt a more holistic approach to mental health, emphasizing the importance of reliable diagnosis in delivering effective treatment plans. As awareness increases and stigma decreases, the uptake of these diagnostic methods is expected to contribute significantly to improving mental health support across the UK.

    Depression Screening Mental Health Market End User Insights

    Depression Screening Mental Health Market End User Insights

    The UK Depression Screening Mental Health Market shows a diverse End ser landscape, prominently featuring Hospitals and Clinics, Home-based settings, and Research and Academic Institutes. Hospitals and Clinics are essential as they offer immediate access to properly trained professionals and resources for effective treatment, making them critical in managing patient care. Home-based screening services have gained popularity, allowing individuals to access mental health support in the comfort of their homes, thus improving engagement and compliance.This shift reflects a wider trend of prioritizing patient-centered care. 

    Research and Academic Institutes contribute significantly to the advancement of diagnostic tools and treatment methodologies, fostering innovation in the sector. By focusing on research, these institutes help shape future practices in the UK’s mental health landscape, ensuring that the most up-to-date information is available to practitioners. Overall, these distinct segments are foundational in addressing the increasing demand for mental health services, underlining the importance of various channels in reaching individuals who may otherwise lack access to essential care.

    Get more detailed insights about UK Depression Screening Mental Health Market Research Report - Forecast to 2035

    Regional Insights

    Key Players and Competitive Insights

    The UK Depression Screening Mental Health Market is characterized by a complex competitive landscape shaped by a range of stakeholders, including governmental organizations, non-profits, and private entities providing mental health services and solutions. This sector has been increasingly recognized for its critical role in addressing the mental health crisis, particularly depression, which affects a significant portion of the population. A multitude of screening tools, assessment methods, and therapeutic interventions are available, reflecting the diversity of approaches taken to improve mental health outcomes. 

    Competition in this market is driven by various factors such as the growing awareness of mental health issues, an increase in government funding, and the rise of digital health solutions that facilitate accessible screening processes. As demand for effective mental health services continues to surge, organizations in this realm are continually evolving to integrate technology and innovative practices to enhance their service offerings.Within this competitive space, the National Health Service (NHS) holds a prominent position in the UK Depression Screening Mental Health Market. The NHS benefits from a comprehensive infrastructure, ensuring widespread access to mental health services across the UK. 

    Its primary strength lies in its established credibility and extensive network of healthcare providers offering standardized screening processes that are integrated into general healthcare systems. The NHS has significantly influenced the landscape of mental health services through initiatives aimed at increasing awareness and decreasing stigma around depression. By providing a range of resources including free mental health assessments, access to counseling, and support groups, the NHS plays a pivotal role in improving early diagnosis and treatment of depression among the populace.

    Additionally, government policies support NHS initiatives, contributing to the organization's strong presence in the market.Samaritans has established itself as a vital entity within the UK Depression Screening Mental Health Market, primarily known for its helpline services that offer emotional support to individuals in crisis. 

    This organization focuses on providing accessible mental health services and is recognized for its dedicated work in promoting mental well-being through listening services, online chat options, and outreach programs targeting at-risk communities. Samaritans' strengths lie in its strong brand awareness and reputation for compassionate, confidential support. The organization continually engages in partnerships and collaborations to expand its reach and effectiveness in addressing issues related to depression. While mergers and acquisitions are less common in the non-profit sector, Samaritans has successfully managed collaborations with various stakeholders to enhance its service offerings. 

    This approach reflects its commitment to adapting to the evolving needs of the mental health landscape in the UK, ensuring that it remains an essential resource for individuals seeking assistance with depression and related mental health challenges.

    Key Companies in the UK Depression Screening Mental Health Market market include

    Industry Developments

    The UK Depression Screening Mental Health Market has seen significant developments recently. Notably, the National Health Service (NHS) continues to enhance its mental health services, integrating digital technologies to assess and screen for depression more effectively. Noteworthy collaborations have arisen among organizations such as Samaritans and Mind to improve awareness and accessibility of mental health resources. In September 2023, Talkspace announced a strategic partnership with NHS to provide virtual therapy sessions aimed at reaching underserved populations across the country. These advancements are vital, given the increasing recognition of mental health issues exacerbated by the COVID-19 pandemic. 

    Furthermore, Psychology Aotearoa and BetterHelp have been expanding their presence in the UK, demonstrating a growing demand for accessible mental health services. In recent years, the market has experienced a notable valuation increase, driven by heightened awareness and destigmatization of mental health, along with support from organizations like Bupa and The Royal College of Psychiatrists. The robust growth trajectory indicates an ongoing commitment from stakeholders to prioritize mental health screening and support services across the UK.

    Market Segmentation

    Outlook

    • Hospitals and Clinics
    • Home-based
    • Research and Academic Institutes

    Report Scope

     
    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 37.23(USD Million)
    MARKET SIZE 2024 39.42(USD Million)
    MARKET SIZE 2035 72.46(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 5.69% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED NHS, Samaritans, Mind, Aetna, Psychology Aotearoa, Talkspace, BetterHelp, Cigna, Priory Group, Liva Healthcare, The Royal College of Psychiatrists, Bupa, Peer Support Network, Headspace
    SEGMENTS COVERED Indication, Diagnosis, End User
    KEY MARKET OPPORTUNITIES Telehealth integration for screenings, AI-driven diagnostic tools, Workplace mental health programs, Preventive screening initiatives, Government healthcare funding expansion
    KEY MARKET DYNAMICS increasing prevalence of depression, government mental health initiatives, advancement in screening technologies, growing awareness and acceptance, integration of digital health solutions
    COUNTRIES COVERED UK

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the expected market size of the UK Depression Screening Mental Health Market in 2024?

    The UK Depression Screening Mental Health Market is expected to be valued at 39.42 million USD in 2024.

    What is the projected market size for the UK Depression Screening Mental Health Market by 2035?

    By 2035, the market is anticipated to reach a valuation of 72.46 million USD.

    What is the estimated CAGR of the UK Depression Screening Mental Health Market from 2025 to 2035?

    The expected compound annual growth rate (CAGR) for this market is 5.69% from 2025 to 2035.

    Which segment is projected to dominate the UK Depression Screening Mental Health Market in 2024?

    The Major Depressive Disorder segment is projected to be valued at 14.5 million USD in 2024.

    What will be the market value for Anxiety Distress in the UK Depression Screening Mental Health Market by 2035?

    The market value for Anxiety Distress is expected to reach 18.8 million USD by 2035.

    Who are the key players in the UK Depression Screening Mental Health Market?

    Major players include NHS, Samaritans, Mind, Aetna, Talkspace, and BetterHelp among others.

    What is the expected market value for Bipolar Disorder in 2024?

    The Bipolar Disorder segment is expected to be valued at 5.5 million USD in 2024.

    What will the market size for Psychotic Disorders be in 2035?

    The market size for Psychotic Disorders is projected to reach 8.4 million USD by 2035.

    What growth trends are anticipated in the UK Depression Screening Mental Health Market?

    Emerging trends include increased emphasis on digital health solutions and personalized care approaches.

    What challenges might impact the UK Depression Screening Mental Health Market in the coming years?

    Challenges may include funding constraints and variations in health policy across regions affecting accessibility.

    1. EXECUTIVE
    2. SUMMARY
    3. Market Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges and Opportunities
    8. Future Outlook
    9. MARKET INTRODUCTION
    10. Definition
    11. Scope of the study
    12. Research Objective
    13. Assumption
    14. Limitations
    15. RESEARCH
    16. METHODOLOGY
    17. Overview
    18. Data
    19. Mining
    20. Secondary Research
    21. Primary
    22. Research
    23. Primary Interviews and Information Gathering
    24. Process
    25. Breakdown of Primary Respondents
    26. Forecasting
    27. Model
    28. Market Size Estimation
    29. Bottom-Up
    30. Approach
    31. Top-Down Approach
    32. Data
    33. Triangulation
    34. Validation
    35. MARKET
    36. DYNAMICS
    37. Overview
    38. Drivers
    39. Restraints
    40. Opportunities
    41. MARKET FACTOR ANALYSIS
    42. Value chain Analysis
    43. Porter's
    44. Five Forces Analysis
    45. Bargaining Power of Suppliers
    46. Bargaining
    47. Power of Buyers
    48. Threat of New Entrants
    49. Threat
    50. of Substitutes
    51. Intensity of Rivalry
    52. COVID-19
    53. Impact Analysis
    54. Market Impact Analysis
    55. Regional
    56. Impact
    57. Opportunity and Threat Analysis
    58. UK
    59. Depression Screening Mental Health Market, BY Indication (USD Million)
    60. Major
    61. Depressive Disorder
    62. Anxiety Distress
    63. Bipolar
    64. Disorder
    65. Psychotic Disorders
    66. Others
    67. UK
    68. Depression Screening Mental Health Market, BY Diagnosis (USD Million)
    69. Psychological
    70. Tests
    71. Blood Tests
    72. Pharmacogenomic
    73. Testing
    74. Others
    75. UK
    76. Depression Screening Mental Health Market, BY End User (USD Million)
    77. Hospitals
    78. and Clinics
    79. Home-based
    80. Research
    81. and Academic Institutes
    82. Competitive Landscape
    83. Overview
    84. Competitive
    85. Analysis
    86. Market share Analysis
    87. Major
    88. Growth Strategy in the Depression Screening Mental Health Market
    89. Competitive
    90. Benchmarking
    91. Leading Players in Terms of Number of Developments
    92. in the Depression Screening Mental Health Market
    93. Key
    94. developments and growth strategies
    95. New Product Launch/Service
    96. Deployment
    97. Merger & Acquisitions
    98. Joint
    99. Ventures
    100. Major Players Financial Matrix
    101. Sales
    102. and Operating Income
    103. Major Players R&D Expenditure.
    104. Company
    105. Profiles
    106. NHS
    107. Financial
    108. Overview
    109. Products Offered
    110. Key
    111. Developments
    112. SWOT Analysis
    113. Key
    114. Strategies
    115. Samaritans
    116. Financial
    117. Overview
    118. Products Offered
    119. Key
    120. Developments
    121. SWOT Analysis
    122. Key
    123. Strategies
    124. Mind
    125. Financial
    126. Overview
    127. Products Offered
    128. Key
    129. Developments
    130. SWOT Analysis
    131. Key
    132. Strategies
    133. Aetna
    134. Financial
    135. Overview
    136. Products Offered
    137. Key
    138. Developments
    139. SWOT Analysis
    140. Key
    141. Strategies
    142. Psychology Aotearoa
    143. Financial
    144. Overview
    145. Products Offered
    146. Key
    147. Developments
    148. SWOT Analysis
    149. Key
    150. Strategies
    151. Talkspace
    152. Financial
    153. Overview
    154. Products Offered
    155. Key
    156. Developments
    157. SWOT Analysis
    158. Key
    159. Strategies
    160. BetterHelp
    161. Financial
    162. Overview
    163. Products Offered
    164. Key
    165. Developments
    166. SWOT Analysis
    167. Key
    168. Strategies
    169. Cigna
    170. Financial
    171. Overview
    172. Products Offered
    173. Key
    174. Developments
    175. SWOT Analysis
    176. Key
    177. Strategies
    178. Priory Group
    179. Financial
    180. Overview
    181. Products Offered
    182. Key
    183. Developments
    184. SWOT Analysis
    185. Key
    186. Strategies
    187. Liva Healthcare
    188. Financial
    189. Overview
    190. Products Offered
    191. Key
    192. Developments
    193. SWOT Analysis
    194. Key
    195. Strategies
    196. The Royal College of Psychiatrists
    197. Financial
    198. Overview
    199. Products Offered
    200. Key
    201. Developments
    202. SWOT Analysis
    203. Key
    204. Strategies
    205. Bupa
    206. Financial
    207. Overview
    208. Products Offered
    209. Key
    210. Developments
    211. SWOT Analysis
    212. Key
    213. Strategies
    214. Peer Support Network
    215. Financial
    216. Overview
    217. Products Offered
    218. Key
    219. Developments
    220. SWOT Analysis
    221. Key
    222. Strategies
    223. Headspace
    224. Financial
    225. Overview
    226. Products Offered
    227. Key
    228. Developments
    229. SWOT Analysis
    230. Key
    231. Strategies
    232. References
    233. Related
    234. Reports
    235. LIST
    236. OF ASSUMPTIONS
    237. UK Depression Screening Mental Health
    238. Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)
    239. UK
    240. Depression Screening Mental Health Market SIZE ESTIMATES & FORECAST, BY DIAGNOSIS,
    241. 2035 (USD Billions)
    242. UK Depression Screening Mental
    243. Health Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)
    244. PRODUCT
    245. LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    246. ACQUISITION/PARTNERSHIP
    247. LIST
    248. Of figures
    249. MARKET SYNOPSIS
    250. UK
    251. DEPRESSION SCREENING MENTAL HEALTH MARKET ANALYSIS BY INDICATION
    252. UK
    253. DEPRESSION SCREENING MENTAL HEALTH MARKET ANALYSIS BY DIAGNOSIS
    254. UK
    255. DEPRESSION SCREENING MENTAL HEALTH MARKET ANALYSIS BY END USER
    256. KEY
    257. BUYING CRITERIA OF DEPRESSION SCREENING MENTAL HEALTH MARKET
    258. RESEARCH
    259. PROCESS OF MRFR
    260. DRO ANALYSIS OF DEPRESSION SCREENING
    261. MENTAL HEALTH MARKET
    262. DRIVERS IMPACT ANALYSIS: DEPRESSION
    263. SCREENING MENTAL HEALTH MARKET
    264. RESTRAINTS IMPACT ANALYSIS:
    265. DEPRESSION SCREENING MENTAL HEALTH MARKET
    266. SUPPLY / VALUE
    267. CHAIN: DEPRESSION SCREENING MENTAL HEALTH MARKET
    268. DEPRESSION
    269. SCREENING MENTAL HEALTH MARKET, BY INDICATION, 2025 (% SHARE)
    270. DEPRESSION
    271. SCREENING MENTAL HEALTH MARKET, BY INDICATION, 2019 TO 2035 (USD Billions)
    272. DEPRESSION
    273. SCREENING MENTAL HEALTH MARKET, BY DIAGNOSIS, 2025 (% SHARE)
    274. DEPRESSION
    275. SCREENING MENTAL HEALTH MARKET, BY DIAGNOSIS, 2019 TO 2035 (USD Billions)
    276. DEPRESSION
    277. SCREENING MENTAL HEALTH MARKET, BY END USER, 2025 (% SHARE)
    278. DEPRESSION
    279. SCREENING MENTAL HEALTH MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    280. BENCHMARKING
    281. OF MAJOR COMPETITORS

    UK Depression Screening Mental Health Market Segmentation

    • Depression Screening Mental Health Market By Indication (USD Million, 2019-2035)

      • Major Depressive Disorder
      • Anxiety Distress
      • Bipolar Disorder
      • Psychotic Disorders
      • Others

     

    • Depression Screening Mental Health Market By Diagnosis (USD Million, 2019-2035)

      • Psychological Tests
      • Blood Tests
      • Pharmacogenomic Testing
      • Others

     

    • Depression Screening Mental Health Market By End User (USD Million, 2019-2035)

      • Hospitals and Clinics
      • Home-based
      • Research and Academic Institutes

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials